Minimally invasive versus open McKeown esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant PD-1 inhibitor plus chemotherapy.
Frontiers in oncology（2023）
摘要
MIE might be safe and feasible for patients with locally advanced ESCC undergoing neoadjuvant PD-1 inhibitor plus chemotherapy.
更多查看译文
关键词
PD-1 inhibitor,esophageal squamous cell carcinoma,minimally invasive esophagectomy,neoadjuvant immunochemotherapy,open surgery
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要